AAAAAA
Results:
1-10
|
Results: 10
Authors:
Gulbrandsen, N
Wisloff, F
Brinch, L
Carlson, K
Dahl, IM
Gimsing, P
Hippe, E
Hjorth, M
Knudsen, LM
Lamvik, J
Lenhoff, S
Lofvenberg, E
Nesthus, I
Nielsen, JL
Turesson, L
Westin, J
Citation: N. Gulbrandsen et al., Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support, MED ONCOL, 18(1), 2001, pp. 65-77
Authors:
Gulbrandsen, N
Wisloff, F
Nord, E
Lenhoff, S
Hjorth, M
Westin, J
Citation: N. Gulbrandsen et al., Cost-utility analysis of high-dose melphalan with autologous blood stem cell support vs. melphalan plus prednisone in patients younger than 60 years with multiple myeloma, EUR J HAEMA, 66(5), 2001, pp. 328-336
Authors:
Bjorkstrand, B
Svensson, H
Goldschmidt, H
Ljungman, P
Apperley, J
Mandelli, F
Marcus, R
Boogaerts, M
Alegre, A
Remes, K
Cornelissen, JJ
Blade, J
Lenhoff, S
Iriondo, A
Carlson, K
Volin, L
Littlewood, T
Goldstone, AH
San Miguel, J
Schattenberg, A
Gahrton, G
Citation: B. Bjorkstrand et al., Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT), BONE MAR TR, 27(5), 2001, pp. 511-515
Authors:
Juliusson, G
Celsing, F
Turesson, I
Lenhoff, S
Adriansson, M
Malm, C
Citation: G. Juliusson et al., Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma, BR J HAEM, 109(1), 2000, pp. 89-96
Authors:
Lenhoff, S
Hjorth, M
Holmberg, E
Turesson, I
Westin, J
Nielsen, JL
Wisloff, F
Brinch, L
Carlson, K
Carlson, M
Dahl, IM
Gimsing, P
Hippe, E
Johnsen, H
Lamvik, J
Lofvenberg, E
Nesthus, I
Rodjer, S
Citation: S. Lenhoff et al., Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study, BLOOD, 95(1), 2000, pp. 7-11
Authors:
Lenhoff, S
Rosberg, B
Olofsson, T
Citation: S. Lenhoff et al., Granulocyte interactions with GM-CSF and G-CSF secretion by endothelial cells and monocytes, EUR CYTOKIN, 10(4), 1999, pp. 525-532
Authors:
Lenhoff, S
Sallerfors, B
Olofsson, T
Citation: S. Lenhoff et al., T lymphocytes downregulate granulocyte-macrophage colony-stimulating factor secretion from stimulated monocytes by increasing the secretion of monocyte-derived interleukin-10, EXP HEMATOL, 27(3), 1999, pp. 410-415
Authors:
Thunberg, U
Banghagen, M
Bengtsson, M
Christensen, LD
Geisler, CH
Lenhoff, S
Mortensen, BT
Olofsson, T
Simonsson, B
Andersen, NS
Sundstrom, C
Swedin, A
Sallstrom, JF
Thuresson, B
Westin, J
Carlson, K
Citation: U. Thunberg et al., Linear reduction of clonal cells in stem cell enriched grafts in transplanted multiple myeloma, BR J HAEM, 104(3), 1999, pp. 546-552
Authors:
Ringden, O
Remberger, M
Ruutu, T
Nikoskelainen, J
Volin, L
Vindelov, L
Parkkali, T
Lenhoff, S
Sallerfors, B
Mellander, L
Ljungman, P
Jacobsen, N
Citation: O. Ringden et al., Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: Long-term results of a randomized trial in allogeneic marrow recipients with leukemia, BLOOD, 93(7), 1999, pp. 2196-2201
Authors:
Swedin, A
Lenhoff, S
Olofsson, T
Thuresson, B
Westin, J
Citation: A. Swedin et al., Clinical utility of immunoglobulin heavy chain gene rearrangement identification for tumour cell detection in multiple myeloma, BR J HAEM, 103(4), 1998, pp. 1145-1151
Risultati:
1-10
|